Merck (MRK) Depreciation and Depletion (2020 - 2025)
Merck (MRK) has disclosed Depreciation and Depletion for 6 consecutive years, with $1.4 billion as the latest value for Q4 2025.
- Quarterly Depreciation and Depletion rose 177.39% to $1.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 billion through Dec 2025, up 26.21% year-over-year, with the annual reading at $3.0 billion for FY2025, 42.59% up from the prior year.
- Depreciation and Depletion for Q4 2025 was $1.4 billion at Merck, up from $449.0 million in the prior quarter.
- The five-year high for Depreciation and Depletion was $1.4 billion in Q4 2025, with the low at $62.0 million in Q2 2025.
- Average Depreciation and Depletion over 5 years is $466.8 million, with a median of $448.0 million recorded in 2022.
- Peak annual rise in Depreciation and Depletion hit 177.39% in 2025, while the deepest fall reached 86.22% in 2025.
- Over 5 years, Depreciation and Depletion stood at $452.0 million in 2021, then decreased by 10.18% to $406.0 million in 2022, then increased by 16.75% to $474.0 million in 2023, then rose by 10.13% to $522.0 million in 2024, then soared by 177.39% to $1.4 billion in 2025.
- According to Business Quant data, Depreciation and Depletion over the past three periods came in at $1.4 billion, $449.0 million, and $62.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.